As expected, a dose-dependent reduction in NF-kB was observed in the groups treated with citicoline, and to a greater extent on addition of Lactobacillus, compared to the NASH group (Fig. 9). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.